Lineage Cell Therapeutics (HyStem Line of products) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Lineage Cell Therapeutics (HyStem Line of products) General Information

Description

Thiolated hyaluronic acid technology based hydrogel products. The technology is used to create 3d hydrogels for cell modified culturing purposes.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 2173 Salk Avenue
  • Suite 200
  • Carlsbad, CA 92008
  • United States
Primary Industry
Buildings and Property
Other Industries
IT Consulting and Outsourcing
Biotechnology
Corporate Office
  • 2173 Salk Avenue
  • Suite 200
  • Carlsbad, CA 92008
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lineage Cell Therapeutics (HyStem Line of products) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Lineage Cell Therapeutics (HyStem Line of products)‘s full profile, request access.

Request a free trial

Lineage Cell Therapeutics (HyStem Line of products) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Lineage Cell Therapeutics (HyStem Line of products)‘s full profile, request access.

Request a free trial

Lineage Cell Therapeutics (HyStem Line of products) FAQs

  • Where is Lineage Cell Therapeutics (HyStem Line of products) headquartered?

    Lineage Cell Therapeutics (HyStem Line of products) is headquartered in Carlsbad, CA.

  • What industry is Lineage Cell Therapeutics (HyStem Line of products) in?

    Lineage Cell Therapeutics (HyStem Line of products)’s primary industry is Buildings and Property.

  • Is Lineage Cell Therapeutics (HyStem Line of products) a private or public company?

    Lineage Cell Therapeutics (HyStem Line of products) is a Private company.

  • What is Lineage Cell Therapeutics (HyStem Line of products)’s current revenue?

    The current revenue for Lineage Cell Therapeutics (HyStem Line of products) is .

  • Who are Lineage Cell Therapeutics (HyStem Line of products)’s investors?

    Lineage Cell Therapeutics has invested in Lineage Cell Therapeutics (HyStem Line of products).

  • When was Lineage Cell Therapeutics (HyStem Line of products) acquired?

    Lineage Cell Therapeutics (HyStem Line of products) was acquired on 14-Jan-2020.

  • Who acquired Lineage Cell Therapeutics (HyStem Line of products)?

    Lineage Cell Therapeutics (HyStem Line of products) was acquired by Advanced BioMatrix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process